Journey Medical Corp (DERM)
3.54
-0.04
(-1.12%)
USD |
NASDAQ |
May 10, 16:00
3.54
0.00 (0.00%)
After-Hours: 18:49
Journey Medical Revenue (TTM): 79.18M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 79.18M |
| September 30, 2023 | 79.89M |
| June 30, 2023 | 61.47M |
| March 31, 2023 | 62.59M |
| December 31, 2022 | 73.67M |
| September 30, 2022 | 75.22M |
| Date | Value |
|---|---|
| June 30, 2022 | 78.71M |
| March 31, 2022 | 75.71M |
| December 31, 2021 | 63.13M |
| September 30, 2021 | 59.34M |
| June 30, 2021 | 49.18M |
| March 31, 2021 | 43.30M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
43.30M
Minimum
Mar 2021
79.89M
Maximum
Sep 2023
66.78M
Average
68.40M
Median
Revenue (TTM) Benchmarks
| Fortress Biotech Inc | 84.51M |
| Puma Biotechnology Inc | 226.63M |
| GT Biopharma Inc | -- |
| FibroGen Inc | 167.49M |
| Outlook Therapeutics Inc | -- |